177 related articles for article (PubMed ID: 22588166)
1. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
[TBL] [Abstract][Full Text] [Related]
2. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
Al-Moujahed A; Nicolaou F; Brodowska K; Papakostas TD; Marmalidou A; Ksander BR; Miller JW; Gragoudas E; Vavvas DG
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4175-85. PubMed ID: 24781943
[TBL] [Abstract][Full Text] [Related]
4. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
6. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
7. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
8. Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.
Ducommun S; Ford RJ; Bultot L; Deak M; Bertrand L; Kemp BE; Steinberg GR; Sakamoto K
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E688-96. PubMed ID: 24425763
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
10. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology.
Kodiha M; Ho-Wo-Cheong D; Stochaj U
Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1307-15. PubMed ID: 21918180
[TBL] [Abstract][Full Text] [Related]
12. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival.
Woodard J; Platanias LC
Biochem Biophys Res Commun; 2010 Jul; 398(1):135-9. PubMed ID: 20599746
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass.
Shah M; Kola B; Bataveljic A; Arnett TR; Viollet B; Saxon L; Korbonits M; Chenu C
Bone; 2010 Aug; 47(2):309-19. PubMed ID: 20399918
[TBL] [Abstract][Full Text] [Related]
18. Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle.
Park S; Scheffler TL; Gunawan AM; Shi H; Zeng C; Hannon KM; Grant AL; Gerrard DE
Am J Physiol Cell Physiol; 2009 Jan; 296(1):C106-15. PubMed ID: 18971392
[TBL] [Abstract][Full Text] [Related]
19. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways.
Jing M; Cheruvu VK; Ismail-Beigi F
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1071-82. PubMed ID: 18701654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
